- Zokinvy increases survival by 2.5 years in children and young adults with Progeria
- Rare Pediatric Disease Priority Review Voucher issued to Eiger from FDA
- Eiger to host an investor call, November 23, at 8:30 AM ET / 5:30 AM PT
PR Newswire
PALO ALTO, Calif., Nov. 20, 2020